-
Lab+Life Scientist brings together the best features of
established titles, What’s New in Lab and Australian Life
Scientist. Since the early 90s these magazines (and their sister
websites) have kept government, industry, private and public lab
managers and scientists up to date with the latest news, products
and developments.
ONE magazine TWO websites THREE eNewsletters
Analytical | Biotech | Environmental | Industrial | Life
Sciences | Medical
www.labonline.com.au | www.lifescientist.com.au
Australia’s ScIENcE & LABorAtory MuLtI-chANNEL marketing
brand
-
Target Audiencethe Lab+Life Scientist opt-in audience covers
laboratories
nationwide, relevant government research facilities and
departments,
biotechnology companies, research institutes, universities,
hospitals,
pathology labs and pharmaceutical firms.
KEy joB tItLES INcLudE
Editorial ContentEditorial coverage extends across all
laboratory and science sectors including: analytical, chemistry,
genetics,
genomics, protein, proteomics, peptides, cancer, infection &
immunity, stem cells, environmental, microscopy &
image analysis, microarrays, microbiology, rNA, epigenetics,
immunology, virology, next generation sequencing,
biomedical research, bio informatics, drug discovery, clinical
research & trials.
there is a dedicated biotechnology section online at
www.lifescientist.com.au/biotechnology. this section is in
partnership with AusBiotech, and editorial features on
biotechnology run twice a year in the magazine.
DistributionEvery laboratory facility in Australia (government
and private), including universities, hospitals,
biotech, research, industrial, environmental and clinical.
Qualified readership includes
department heads, researchers, lab management, and senior
scientific and technical officers.
combining the best of What’s New in Lab + Life Sciences and
Australian Life Scientists’ audited (cAB) readers,
plus additional circulation at the listed events, guarantees
7,200 print magazines will be distributed every issue.
An eMag version is sent out to just under 3,000 digital
subscribers.
Medical Scientist | Research Fellow | Chief Scientist
Lab Manager Senior Microbiologist | Research | Scientist
Laboratory Director Principal Scientist | Department Head
Lab Director | Senior Chemist | National Pharma Manager | NMR
Facility | ManagerResearch Pathologist
www.labonline.com.au | www.lifescientist.comau
ConferencesLab+Life Scientist supports, and is distributed at
the leading lab, science and biotechnology conferences each
year. Advertisers benefit from bonus circulation at these
events, and more.
Lorne | AusBiotech | ComBio | ASM | ASI | ARCS | Pathology
Update| ANS | Lab Managers
AACB | RACI | OzWater | ASMR | AHMRC
-
Magazine circulation - 7,200labonline enewsletter - 2,573 |
lifescientist enewsletter 1,811 | eMag: 2,723
*names protected by our Privacy Policy - all these subscribers
have registered for the magazine (free subscription) and/or
Labonline or Lifescientist eNewsletters.
VP OPERATIONS ALLIED HEALTHCARE GROUP
HISTOLOGY SCIENTIST ANATPATH
RESEARCH SCIENTIST CSIRO
QA HUNTER VALLEY QUALITY MEATS
SENIOR RESEARCH FELLOW EPWORTH RESEARCH INSTITUTE
LAB MANAGER GRIFFITH UNIVERSITY
VP GENERAL MANAGER IKARIA AUSTRALIA
RESEARCH SCIENTIST INSTITUTE OF HUMAN VIROLOGY
MEDICAL SCIENTIST MATER HEALTH SERVICES
PROJECT MANAGER MELANOMA INSTITUTE
ANALYTICAL CHEMIST AUSTRALIAN ANTARCTIC DIVISION
LABORATORY MANAGER MYGENE
DIRECTOR ADELAIDE UNI PROTEOMICS
MEDICAL SCIENTIST PATHWEST
MANAGING DIRECTOR PROGEN PHARMACEUTICALS
SCIENTIST QLD MEDICAL LABORATORY
LABORATORY MANAGER SA PATHOLOGY
VACCINE MANAGER SANOFI
GENERAL MANAGER SUGAR RESEARCH AUSTRALIA
CEO TGR BIOSCIENCES
ASSOC PROF FORENSIC BIOLOGY UTS
GENERAL MANAGER VIFOR PHARMA
HOSPITAL SCIENTIST WESTMEAD HOSPITAL
RESEARCH SCIENTIST AUSTRALIAN RACING FORENSIC LABORATORY
CHIEF TECHNOLOGY OFFICER CHILDREN’S MEDICAL RESEARCH
INSTITUTE
SNR RESEARCH SCIENTIST DEPT ENVIRONMENT & PRIMARY
INDUSTRIES
SENIOR SCIENTIST FOOD STANDARDS AUSTRALIA NEW ZEALAND
MANAGER SKIN CULTURE CENTRE
ROYAL BRISBANE & WOMEN’S HOSPITAL
VP CLINICAL AND REGULATORY AFFAIRS
SPINIFEX PHARMACEUTICALS
RESEARCH FELLOW ST VINCENT’S INSTITUTE OF MEDICAL RESEARCH
CHIEF SCIENTIST DAIRY FOOD SAFETY VICTORIA
AQUACULTURE & LAB TECH BAY OF PLENTY POLYTECHNIC
TECHNICAL SPECIALIST BIO FUTURE
LABORATORY ANALYST BLUESCOPE STEEL
QA/QC BULLA DAIRY FOODS
HEAD OF MICROBIOLOGY GRIBBLES PATHOLOGY
LAB SERVICES MANAGER CHARLES PERKINS CENTRE
MEDICAL SCIENTIST EASTERN HEALTH
LAB TECH LEAD GEORGE WESTON FOODS
QUALITY SYSTEMS ENGINEER GM HOLDEN
LAB MANAGER LUDWIG INST FOR CANCER RESEARCH
LABORATORY TECHNICIAN HEALTHSCOPE PATHOLOGY
FISH VIROLOGIST CSIRO
QUALITY MANAGER LIGHTLAB INTERNATIONAL
LABORATORY MANAGER MCLAREN VINTNERS
QUALITY MANAGER MURRAY GOULBURN
LAB TECH OFFICER RHEEM AUSTRALIA
LABORATORY SCIENTIST RMIT
HACCP MANAGER ROYAL FOODS AUSTRALIA
LAB MANAGER AUST GENOME RESEARCH FACILITY
MANAGING SCIENTIST PATHWEST LAB MEDICINE WA
LAB MANAGER UNIVERSITY OF QUEENSLAND
VIROLOGIST WOOLCOCK INSTITUTE
LABORATORY MANAGER AUSTRALIAN GEOCHEMICAL SURVEY
COMPLIANCE OFFICER AQ FREEDOM NUTRITIONAL PRODUCTS
MEDICAL LABORATORY SCIENTIST
HEALTHSCOPE PATHOLOGY
LABORATORY MANAGER MONASH INSTITUTE OF MEDICAL RESEARCH
SENIOR CONSULTING MICROBIOLOGIST
ADVANCED ANALYTICAL AUSTRALIA
LABORATORY HEAD WALTER & ELIZA HALL INST OF MEDICAL
RESEARCH
LAB MANAGER SULLIVAN NICOLAIDES PATHOLOGY
AuDiEnCE snApshoTA sample selection of opt-in subscribers* from
our lab+life science channel
www.labonline.com.au | www.lifescientist.comau
-
SEPTEMBER 2014 Feature topics: food science / bioscience
conferences: combio / foodtech Packtech
11/08/14 02/09/14 16/09/14
OCTOBER 2014 Feature topics: biotechnology / lab automation
conferences: ausbiotech / lab Managers conf / aHMrc
02/09/14 30/09/14 15/10/14
NOVEMBER 2014 Feature topics: Microscopy / immunology
conferences: asi / raci
13/10/14 04/11/14 18/11/14
JANUARY 2015 Feature topics: sample Prep / genomics + Proteomics
conferences: lorne / Pathology update
05/12/14 09/01/15 23/01/15
MARCH 2015 Feature topics: cell biology / liquid Handling
Special report: funding update
10/02/15 04/03/15 18/03/15
MAY 2015 Feature topics: biochemistry / Qa conferences: ozwater
/ asMr
08/04/15 30/04/15 14/05/15
JUNE 2015 Feature topics: clinical trials / Microbiology
conferences: arcs / asM / raci
13/05/15 04/06/15 19/06/15
aD + eDitorial
Material DeaDline
insert to
MailHouse
to
reaDers
eDitorial guiDelines
www.westwick-farrow.com.au/pages/supply_edit.asp
editor - Janette woodhouse | [email protected]
Editorial + Events Calendarsept 2014 - Jun 2015
-
aDvertising artwork sPecifications anD PreferreD file forMats
can be revieweD Here
http://www.westwick-farrow.com.au/pages/material_specs.asp
print Advertising Rates + specs
rates effective 01/01/2014. rates subject to 10% Goods &
Service tax.
FOUR COLOUR CASUAL $ 3 X $ 6 X $
full Page 3900 3100 2700
1/2 Page 2456 2010 1800
1/3 Page 1850 1550 1400
1/4 Page 1470 1240 1100
Lab + Life Scientist is committed to the Australian market. It
delivers multiple audience
touchpoints for your next marketing campaign like no other can.
Ask your Account
Manager about cross-channel packages to incorporate print,
online, eNewsletter and lead
generation options.
p r e m i u m p o s t i o n s +10% rate loading for inside front
cover, outside back cover + early right-hand pages
i n s e r t scost to insert varies depending on weight and other
factors. due to
complex postal regulations, each insert can only be costed after
accurate
weight and coverage requirements are supplied. State runs are
accepted.
DPs $555 full Page $405 1/2 Page $250
1/3 Page $175 1/4 Page $150 1/8 Page $100
MATERIAL SIZE WIDTH DEPTH
mm mm
dPS trim 420 297
dPS Bleed 430 307
Full-Page trim 210 297
Full-Page Bleed 220 307
Full-Page Live type 180 270
half-Page horizontal 180 135
D e s i g n C h a r g e s
MATERIAL SIZE WIDTH DEPTH
mm mm
half-Page Vertical 88 270
one-third Vertical 57 270
one-third horizontal 180 90
Quarter-Page Standard 88 135
Quarter-Page Vertical 42 270
Quarter-Page horizontal 180 67
p r i n t s p e c i f i c a t i o n s
M a g a z i n e D i s p l a y A d v e r t i s i n g
-
Topic Centres:
• Analytical instrumentation
• Life science & clinical diagnostics instruments
• Laboratory equipment
• research & development
• Lab design, fit-out & services
• computing hardware/software
• consumables
• Lab business
WFonline MediaYour Network of 12 industry-specific sites offers
visitors a content-rich user experience, with thousands of archived
articles easily accessible via enhanced search, industry
directories and eNewsletter updates. Membership of any site gives
readers access to ALL content across the network.
www.electronicsonline.net.auwww.foodProcessing.com.auwww.ecDsolutions.com.auwww.safetysolutions.net.au
www.technologyDecisions.com.auwww.Poolandspareview.com.auwww.sustainabilityMatters.net.auwww.fieldservicebusiness.com.au
** contact your Account Manager for our full WFonline Media
Kit.
LabOnline.com.au delivers vital information (new products, white
papers, applications, technology advances & news) to
science and laboratory professionals. It focuses on
biotechnology, clinical diagnostics, analytics, research, quality
assurance
and education. An eNewsletter service delivers site updates to
members.
Labonline.com.auFrom the publishers of Lab + Life Scientist
magazine
• Banner advertising
• eNewsletter Sponsorship
• Site sponsorship (by topic)
Traffic Stats: Average per month
November 13 to April 14 average
Visits 6,007
Page Views 11,850
Source: Google Analytics
Weekly eNewsletter 3,766 subscribers (Mar 14)
www.Processonline.com.auwww.criticalcomms.com.auwww.labonline.com.auwww.lifescientist.com.au
cost-effective marketing packages** are available across the
WFonline Network
• Lead generation (White paper & eBooks)
• hot Product sponsorships
• Microsites (premium directory listings)
-
Lifescientist.com.au Monthly visits: 13,562 | page views:
19,185
Standard run-of-site display advertising
Minimum 20% SOV guarantee
• Leaderboard $1,650 per quarter [728 pixels wide x 90 pixels
high]
• 1st M-Rec $1,650 per quarter [300 pixels wide x 250 pixels
high]
• 2nd M-Rec $1,200 per quarter [300 pixels wide x 250 pixels
high]
• Premier Text Link $1,650 per quarter [Logo plus 25 words +
embedded live URL]
LEADERBOARD
M-REC 1
PREMIER TEXT LINK
M-REC 2
Weekly enewslettersubscribers: 2,088
Display banners and text link options (exclusive)
Monthly blocks ensure minimum of 4 broadcasts (weekly)
• 1st M-Rec Ad $800 per month [300 pixels wide x 250 pixels
high]
• 2nd M-Rec Ad $600 per month [300 pixels wide x 250 pixels
high]
• Text Panel $800 per month [company logo, bold header + 30
words text, live URL link embedded]
M-REC 1
M-REC 2
TEXT PANEL
Nov 13 to Apr 14 average
(Mar 2014)
-
inTRoDuCing AppnoTEs A new, highly targeted marketing option
from Lab+Life scientist
WHAT IS IT?
AppNotes are one-page ‘application articles’ covering the
technology, application or performance of a new product or
technique
relevant to those working in analytical, environmental, life
science, medical and research laboratories.
WHO CAN SUBMIT AN APPNOTE?
Any company that supplies products or services to the research,
analytical, biotech and life science sectors. A maximum of SIX
AppNotes will appear in any single issue of Lab+Life Scientist
and are available on a first-booked basis.
WHAT FORMAT ARE SUBMISSIONS TO BE MADE IN?
All AppNotes are subject to editorial approval and may be edited
to fit the guidelines below. the AppNote should focus on the
application or technique, not on the vendor organisation or
technical product details.
HOW WILL APPNOTES APPEAR IN THE MAGAZINE, AND IS THERE WEB AND
ENEWS COVERAGE?
AppNotes will have their own section in each
issue of Lab+Life Scientist and will appear on
consecutive pages. they will run following the main
feature articles, news and interviews, and before the
New Products section. AppNotes will have their own
section on both Labonline and LifeScientist websites
and will also be published in one site update
eNewsletter.
PRICE
AppNotes are available at the same price as a
standard full-page advertisement.
AppNotes are 550–600 words and must include one image (photo or
graph/table). Use the below as a formatting guide.
• Title (up to 60 characters) plus abstract (up to 25 words)
• Introduction
• Description of the technology underlying the
product/technique
• Flexibility of application• Conclusion (outcome/result)• URL
of supplier’s website and company logo
IMAge: high resolution tiff or jpeg (300 dpi and 13.5 cm
min).
Logo: eps (preferred), tiff or jpeg (300 dpi).
AppNot
es
When the changes to Employee Share Schemes (ESSs)
were announced in 2009, the measures were predicted
by industry to result in less incentive for employees
and greater administrative costs for companies, and
subsequently result in companies turning away from
the use of such schemes. It was feared that the changes,
notably the taxing of shares upon issue instead of
when a profit is realised, would undermine innovation
in start-up biotechnology companies and there was a
significant ground swell of opposition.
And so it was. Anecdotally, many start-up companies
in the biotechnology sector reported grudgingly turning
to alternative, less satisfactory, methods to retain,
incentivise and reward employees.
In the months after the changes were implemented,
AusBiotech spoke with key accounting firms, made a
submission to the government in 2009 and began to
advocate on behalf of its members - and continues
to call for a repeal of the changes. This new burden
on companies seemed to be aimed at the top end of
town and had wrongly captured small, rapidly growing
companies that often do not have the ability to reward
employees with cash and so use shares and options as
incentives and future rewards.
Most start-up companies are funded by means other
than sales revenue, such as venture capital or share
issues, and require those funds to conduct research and
development and prepare a product to earn revenue. In
this ‘cash pressed’ state they often rely on the support of
ESSs to attract quality employees, and are an important
support in enabling innovative start-up companies to
establish. ESSs complement cash remuneration, making
a salary package appear more substantive and attractive,
in addition to the mutual benefit of giving employees a
vested interest in the success of the company.
The importance of ESSs is especially poignant and
amplified in the biotechnology sector, where the pre-
revenue phase is typically extended by the need to
clear regulatory hurdles before revenue can be earned
- sometimes by more than a decade - and the cash
required to reach regulatory approval.
Last year a Review of ESSs was instigated and
concluded in February 2014. AusBiotech recommended
to the review that taxing shares should occur at the
time of liquidation/realisation, when market valuation
is known, rather than at the time of issue, when value
is uncertain.
Many employers in a start-up context cannot offer
market salaries, so an ESS enables them to compete
for appropriately qualified talent.
An ESS works best as an incentive when tax is paid
on success. If tax is charged pre-success or pre-gain,
the shares come as a cost to the employee, with the tax
payable before any value is generated. It is even worse
when the share loses value, becomes worthless or is
diluted when more shares are issued. This is comparable
to paying income tax before you earn any income or
paying tax in advance for an income that you may or
may not receive. This method of taxation is a disincentive
and disadvantages start-up innovative companies during
the establishment and development phases.
Furthermore, the current situation of pre-gain tax
means that companies must provide valuations of their
capitalisation value, for use by the ATO. Biotechnology
companies are notoriously difficult - and therefore
expensive - to value. It is an inexact process, fraught
with uncertainty.
Laboratory Gas Generators: Reliability, control key issues
www.eppendorf.com/cellmanipulationEppendorf®, the Eppendorf
logo, TransferMan®, InjectMan® and Eppendorf PiezoXpert® are
registered trademarks of Eppendorf AG, Hamburg, Germany. All rights
reserved, including graphics and images. Copyright© 2013 by
Eppendorf AG.
> Unprecedented movement control> Pre-defi ned functions
for various
applications optimize your workfl ow> Connection with
Eppendorf electronic microinjectors and Eppendorf PiezoXpert®
The new Eppendorf micromanipulators are developed to simplify
your work and increase your micromanipulation results.The robust
and reliable devices are ergonomically correct and function with
maximum stability, providing the best performance for the easiest
operation.
New Eppendorf micromanipulators TransferMan® 4r and InjectMan®
4
Smooth Operator
www.eppendorf.com/cellmanipulationEppendorf®, the Eppendorf
logo, TransferMan®, InjectMan® and Eppendorf PiezoXpert® are
registered trademarks of Eppendorf AG, Hamburg, Germany. All rights
reserved, including graphics and images. Copyright© 2013 by
Eppendorf AG.
> Unprecedented movement control> Pre-defi ned functions
for various
applications optimize your workfl ow> Connection with
Eppendorf electronic microinjectors and Eppendorf PiezoXpert®
The new Eppendorf micromanipulators are developed to simplify
your work and increase your micromanipulation results.The robust
and reliable devices are ergonomically correct and function with
maximum stability, providing the best performance for the easiest
operation.
New Eppendorf micromanipulators TransferMan® 4r and InjectMan®
4
Smooth Operator
www.eppendorf.com
Many employers in a start-up context cannot offer market
salaries, so an ESS enables them to compete for appropriately
qualified talent.
SAMPLE
TEXT
APPNOTE SUBMISSION GUIDE
-
eDitorial: janette Woodhouse — [email protected]
Williamson — [email protected]
aDvertising: [email protected]
MeDia
www.westwick-farrow.com.au | +61 2 9487 2700 AUG 2014
T h e e x p e r t s i n t e c h n o l o g y &
i n d u s t r i a l B 2 B m e d i a
For over 32 years, Westwick-Farrow Media has
been delivering must-have business information
to industrial and technology professionals across
a range of vertical industry sectors. A mix of
magazines (print + digital), eNewsletters, websites
and targeted events provides decision makers with
up-to-the-minute product information, technology
applications, solutions and how-to tips, along
with breaking technology news and industry
commentary.
Westwick-Farrow Media’s media channels include
11 industry-specific magazines and related
websites, dozens of informative eNewsletters,
along with a growing list of niche, targeted events
— all aimed at building community and delivering
information where, how and when our members
want to receive it.
